Alzheimer's disease (AD) is a neurodegenerative disorder in which oxidative stress has been implicated as an important event in the progression of the pathology. In particular, it has been shown that protein modification by reactive oxygen species (ROS) occurs to a greater extent in AD than in control brain, suggesting a possible role for oxidation-related decrease in protein function in the process of neurodegeneration. Oxidative damage to proteins, assessed by measuring the protein carbonyl content, is involved in several events such as loss in specific protein function, abnormal protein clearance, depletion of the cellular redox-balance and interference with the cell cycle, and, ultimately, neuronal death. The present investigation represents a further step in understanding the relationship between oxidative modification of protein and neuronal death in AD. Previously, we used our proteomics approach, which successfully substitutes for laborintensive immunochemical analysis, to detect proteins and identified creatine kinase, glutamine synthase and ubiquitin carboxy-terminal hydrolase L)1 as specifically oxidized proteins in AD brain. In this report we again applied our proteomics approach to identify new targets of protein oxidation in AD inferior parietal lobe (IPL). The dihydropyrimidinase related protein 2 (DRP-2), which is involved in the axonal growth and guidance, showed significantly increased level in protein carbonyls in AD brain, suggesting a role for impaired mechanism of neural network formation in AD. Additionally, the cytosolic enzyme a-enolase was identified as a target of protein oxidation and is involved the glycolytic pathway in the pathological events of AD. Finally, the heat shock cognate 71 (HSC-71) revealed increased, but not significant, oxidation in AD brain. These results are discussed with reference to potential involvement of these oxidatively modified proteins in neurodegeneration in AD brain.
The balance between oxidized protein formation and degradation is a complex function that reflects the balance between reactive oxygen species (ROS) formation and antioxidant defense. When the demand on the cell's ability to detoxify harmful radicals is not met, then cellular modification can occur. In Alzheimer's disease (AD), where reactive substances have been implicated in the progression of this agerelated neurodegenerative disease, protein carbonyl levels, considered a detectable marker of protein oxidation, are increased in several regions of the brain (Markesbery 1997; Butterfield and Kanski 2001; Butterfield and Lauderback 2002) . Chemical modification of proteins, resulting from direct ROS attack on amino acids or by covalent binding to products of lipid peroxidation or glycoxidation (Butterfield and Stadtman 1997; Dean et al. 1997) , appears to play an important role in neurodegeneration, because oxidative damage leads to loss in specific protein function. For instance, the citric acid key enzyme aconitase presents decreased activity as its protein carbonyl content increases with aging in flies (Yan et al. 1997) Additionally, glutamine synthase, which plays a crucial role in balancing the potentially excitotoxic effect of glutamate, and the activity of which is decreased in AD brain (Hensley et al. 1995; , has been identified as specifically oxidized enzyme in AD compared with control brain (Castegna et al. 2002) . Further, creatine kinase (BB isoform), which has decreased activity in AD brain (Hensley et al. 1995) , is specifically oxidized in AD brain as indexed by increased carbonyl content (Aksenov et al. 2000; Castegna et al. 2002) . Several studies demonstrated that the carbonyl content of proteins increases as a function of aging, a condition in which proteins are more prone to oxidation (Sohal et al. 1995) . The metabolic consequences of accumulation of ineffective oxidized proteins seem to play an important role in the cell (Stadtman 1990 ). When not degraded by specific proteases, oxidatively modified proteins can deposit as proteolysis-resistant protein aggregates (Berlett and Stadtman 1997) . In addition, protein oxidation products could affect cell growth and differentiation (Dean 1997; Kamata et al. 2001) .
As a fundamental step in establishing a relationship between protein oxidation and neurodegeneration in AD, we have identified specific targets of protein oxidation with 2D-gel fingerprinting of oxidized proteins and immunochemical detection of protein carbonyls coupled with mass spectrometry and database search (Castegna et al. 2002) . Creatine kinase, glutamine synthase and ubiquitin carboxy-terminal hydrolase L)1 were successfully detected as significantly more oxidized proteins in AD versus control brain by applying proteomics techniques. Proteomics offers the advantage of achieving fast and reliable protein identification from excisable gel spots, without the laborious process of determining protein identity following staining with specific antibodies.
In this study, we report three additional targets of protein oxidation in AD brain. Dihydropyrimidinase related protein-2 (DRP-2), which is involved in axonal growth and guidance, showed a significantly increased level in protein carbonyls in AD brain, suggesting a role for impaired mechanism of neural network formation in AD. Additionally, the cytosolic enzyme a-enolase was also identified as a target of protein oxidation, involving the glycolytic pathway in the pathological events of AD. Finally, the heat shock cognate 71 (HSC-71) revealed increased, but not significant, oxidation levels in AD. The results are discussed with implications for neurodegeneration in AD.
Materials and methods

Brain sampling
Inferior parietal lobule tissue samples used for analyses were taken at autopsy from five AD patients and five control subjects, immediately frozen in liquid nitrogen, and stored at )80°C. The Rapid Autopsy Program of the University of Kentucky Alzheimer's Disease Research Center (UK ADRC) provides extremely short post-mortem interval (PMI) specimens. Demographic data for the patients are presented in Table 1 . All AD subjects displayed progressive intellectual decline and met NINCDS-ADRDA Workgroup criteria for the clinical diagnosis of probable AD (McKhann et al. 1984) . All AD subjects met accepted guidelines for the histopathologic diagnosis of AD (National Institute on Aging and the Reagan Institute Working Group 1997). Hematoxylin-eosin and modified Bielschowsky staining and 10-D-5, ubiquitin, and a-synuclein immunohistochemistry were used on multiple neocortical, hippocampal, entorhinal, amygdala, brainstem and cerebellum sections for diagnosis. Some AD patients were also diagnosed with dementia with Lewy bodies, but the results of this study were no different from AD patients with or without the presence of Lewy bodies. Control subjects underwent annual mental status testing as a part of the UK ADRC normal volunteer longitudinal aging study, and did not have a history of dementia or other neurologic disorders. All control subjects had test scores in the normal range. Neuropathologic evaluation of control brains revealed only age-associated gross and histopathologic alterations.
Brain samples were minced and suspended in 10 mM HEPES buffer (pH 7.4) containing 137 mM NaCl, 4.6 mM KCl, 1.1 mM KH 2 PO 4 , 0.6 mM MgSO 4 and proteinase inhibitors: leupeptin (0.5 mg/mL), pepstatin (0.7 lg/mL), type IIS soybean trypsin inhibitor (0.5 lg/mL), and PMSF (40 lg/mL). Homogenates were centrifuged at 14 000 g for 10 min to remove debris. Protein concentration in the supernatant was determined by the BCA method (Pierce, Rockford, IL, USA).
2D-gel electophoresis and western blotting 2D-polycarylamide gel eletrophoresis (PAGE) was performed in a Multiphor II Electrophoresis system using 110-mm pH 3-10 Immobiline DryStrips and ExcelGel XL 12-14 gels (Amersham Pharmacia Biotech, Piscataway, NJ, USA). Derivatization of brain proteins was accomplished according to the procedure of Levine et al. (1994) . Carbonyl groups, that are introduced into amino-acid side chain following oxidative modification of proteins (Butterfield and Stadtman 1997) , were detected by reaction with 2,4-dinitrophenylhydrazine (DNPH). The dinitrophenylhydrazone derivative that is produced by this reaction was immunodetected by using a specific anti-DNPH-protein adduct antibody. Samples were incubated with agitation for 30 min at room temperature (25°C) after addition of four volumes of 10 mM DNPH/2 M HCl for Oxyblot, or 2 M HCl for proteomics analysis, and proteins were precipitated by addition of ice-cold 100% trichloroacetic acid to a final concentration of 15%. Precipitates were centrifuged at 14 000 g for 10 min following incubation on ice for 10 min, and the residues were washed with 1 mL of 1 : 1 (v/v) ethanol/ethyl acetate. After centrifugation for 15 min at 15 000 g three times, the samples were resolubilized in 8 M urea to a final protein concentration of 4 mg/mL, and were diluted to 2-4 mg/mL in 8 M urea and mixed 1 : 4 (v/v) with 2D-PAGE sample buffer (8.7 M urea, 1.0% (w/v) dithiothreitol, 2.0% (v/v) Pharmalyte 3-10, 0.5% Triton X-100, and bromophenol blue). For the first-dimension, 100 lg of protein were applied to a rehydrated Immobiline DryStrip, and the isoelectric focusing was carried out at room temperature. Before the second-dimension separation, Immobiline Dry-Strips were equilibrated for 10 min in 50 mM Tris-HCl (pH 6.8) containing 6 M urea, 1% (w/v) sodium dodecyl sulfate (SDS), 30% (v/v) glycerol, and 0.5% dithiothreitol, and then re-equilibrated for 10 min in the same buffer containing 4.5% iodacetamide in place of dithiothreitol. AD and control strips were placed on ExcelGel XL SDS 12-14 gels, unstained molecular standards were applied, and the electrophoresis was started. Isoelectric focusing was performed for 22 700 voltage per hour (Vh). Second dimension gels were run at 1000 V/20 mA for 45 min, followed by 1000 V/40 mA, for 2.5 h.
SYPRO Ruby staining
The gel slabs were fixed in 10% methanol and 7% acetic acid for 30 min. The fixed solution was removed and 500 mL of SYPRO Ruby gel stain (Bio-Rad Laboratories, Hercules, CA, USA) was added to each gel and incubated on gently continuous rocker at room temperature for 18 h. For immunoblotting analysis, the electrophoresis was carried out in the same way as described above, and the gels were transferred to a nitrocellulose membrane. The membranes were incubated with rabbit anti-DNP antibody (Oncor, Gaithersburg, MD, USA) diluted 1 : 150 in 0.3% BSA/PBST for 1 h at room temperature. After incubation with primary antibodies was complete, membranes were washed for 10 min in PBST three times. Secondary antibody (antirabbit alkaline phosphatase-conjugated IgG, Sigma, St Louis, MO, USA), diluted 1 : 30 000 in 0.3% BSA/PBST, was then added to blots for 1 h at room temperature. Membranes were washed three times (10 min per wash) with PBST and developed using 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium (BCIP/NBT) solution (SigmaFast tablets; Sigma).
Sample preparation for MALDI-TOF mass spectrometry Nitrocellulose solution was made by dissolving a nitrocellulose membrane in 1 : 1 acetone/isopropanol solvent. Alpha-cyano-4-hydroxycinnamic acid (a-CN) was washed with 50 lL of acetone and acetone phase was discarded. The a-CN was dissolved in acetone to a concentration of 10 mg/mL and the nitrocellulose and a-CN solutions were mixed to 1 : 4 ratio and 1 lL of this mixture was deposited onto the 96-well MALDI target plate. The samples were prepared for addition to the plate by mixing 2 lL of sample with 2 lL of 10 mg/mL a-CN solution in 0.1% trifluoroacetic acid in 1 : 1 H 2 O/Acetonitrile. The sample mixtures (1 lL) were loaded onto each thin film. After the sample mixtures were dried, 1.5 lL of 2% formic acid in 18 MW water was added to each spot. The formic solution was removed by gentle blotting. This washing step was performed twice. The samples were then dried at room temperature. Fragment size was determined by MALDI-TOF mass spectrometry (MS).
Mass spectral data were obtained using a Micromass TOF-Spec 2E instrument (Micromoss Inc., Beverly, MA, USA) equipped with a 337-nm N2 laser at 20-35% power in the positive ion reflectron mode. Spectral data were obtained by averaging 10 spectra, each of which was the composite of 10 laser firings. The mass axis was calibrated using known peaks from tryptic autolysis.
Analysis of gel images
The analyses of gels and membranes to compare protein and carbonyls content between control and AD samples were performed with HT Analyzer 2D-PAGE software (Genomic Solutions Inc.). Images from SYPRO Ruby-stained gels, used for proteomic analyses were obtained using a high-resolution 12-bit camera with UV light box system (Genomic Solutions Inc., Ann Arbour, MI, USA). Gels were exposed to UV light for five different exposure time-points (1, 2, 3, 4 and 5 s). Coomassie Blue stained gels, used to measure protein content, were scanned with a Scanjet 3300C from Hewlett Packard (Palo Alto, CA, USA).
Analysis of peptide sequences
Peptide mass fingerprinting was used for protein identification from tryptic fragment sizes by using the MASCOT search engine (http:// www.matrxscience.com) based on the entire NCBI and SwissProt protein databases, using the assumption that peptides are monoisotopic, oxidized at methionine residues and carbamidomethylated at cysteine residues. Up to one missed trypsin cleavage was allowed, although most matches did not contain any missed cleavages. Mass tolerance of 150 ppm/g was the window of error allowed for matching the peptide mass values. Probability-based MOWSE scores were estimated by comparison of search results against estimated random match population and were reported as )10*LOG10(p), where p is the absolute probability. Scores greater than 71 were considered significant (p < 0.05) (Fig. 2b) . All protein identifications were in the expected size range based on position in the gel.
Statistical analysis
Statistical comparison of carbonyl levels of proteins, matched with anti-DNP positive spots on 2D-Oxyblots from AD and age-matched control samples, was performed using analysis of variance (ANOVA), with significant difference set at p < 0.05.
Results
Comparison of brain protein oxidation levels in AD versus control subjects was obtained by first identifying proteins containing reactive carbonyl groups in AD and control brain samples through 2D-Oxyblot analysis (Fig. 1a) . 2D-Oxyblots and the subsequent Comassie Blue-stained 2D-gel images (Fig. 1b) from the same sample were matched and the anti-DNP immunoreactivity of individual proteins separated by 2D-PAGE were normalized to their content, obtained by measuring the intensity of the staining. This approach demonstrated that many, but not all, individual protein spots in inferior parietal lobe (IPL) brain extracts exhibit antiprotein carbonyl immunoreactivity (Fig. 1a and b) . We found that the positions of proteins in control and AD 2D-maps were identical, a finding already confirmed by our previous studies (Aksenov et al. 2000 (Aksenov et al. , 2001 Castegna et al. 2002) .
Identification of possible targets of increased protein carbonyls was achieved by using MS analysis. Protein spots used for MALDI MS analysis were excised from 2D-gels obtained with non-DNP-treated samples because pretreatment of proteins with DNPH, which is a necessary step to immunodetect reactive carbonyl groups in proteins, might affect results of MS identification of individual proteins. As shown by our previous findings (Castegna et al. 2002) , comparison between 2D-maps of the same sample, DNPHtreated and untreated, did not show any major differences in protein position, allowing the application of MS analysis to identify proteins. Three brain proteins from the region boxed in Figs 1a and b exhibited increase in specific oxidation levels in AD IPL samples (Fig. 2) . These proteins were successfully identified by MS analysis as DRP-2, a-enolase, and HSC-71. Mass spectra corresponding to tryptic digests of each of identified brain proteins are shown in Fig. 3 . Using MASCOT, the probability based MOWSE score was 144 ( p < 0.05) for DRP-2, with 13/21 peptide matches, 189 ( p < 0.05) for a-enolase, with 14/19 peptide matches, and 125 for HSC-71, with 12/19 peptide matches. We report a significant increase in protein carbonyls in another vulnerable region of the AD brain, IPL, for DRP-2 Fig. 1a) show protein carbonyl immunoreactivity in DRP-2, a-enolase, and HSC-71. (Bottom): Expanded 2D-gel images (boxed in Fig. 1b) show the position of protein spots identified by mass spectrometry. Relative changes in carbonyl immunoreactivity, after normalization of the carbonyl intensities to the protein content, were significant for all three proteins.
(489 ± 52% control, p < 0.02), and a-enolase (321 ± 18% control, p < 0.01). Heat shock cognate-71 showed a nonsignificant increase in protein carbonyls in AD versus control brain (224 ± 63% control, p > 0.05) ( Table 2 ).
Discussion
Recently, we successfully coupled Oxyblot techniques with the powerful tools emerging from proteomics application to biochemistry, 2D-gel fingerprinting for protein separation and MS analysis for protein identification, to define three targets of protein oxidation in AD brain, identified as creatine kinase BB, ubiquitin carboxy-terminal hydrolase L)1, and glutamine synthase, which are specifically oxidized in AD (Castegna et al. 2002) .
Several studies demonstrated that brain protein oxidation occurs in AD (Hensley et al. 1995; Markesbery 1997; , indicating a role for protein alterations in the processes of neuronal defects associated with AD. Impaired metabolism, in which the oxidized, thus ineffective, enzyme is involved, might conceivably participate in cell dysfunction that eventually leads to neuronal death.
The process of axonal growth is a delicate mechanism needed to create contacts between neurons. The process necessary to build the network of connections relies on axonal pathfinding, which represents guidance to the growth target. A variety of diffusible guidance molecules are involved in signaling the correct path of the growing axon. The growth cone, the motile structure at the tip of the growing axon, plays a fundamental role in responding to different guidance cues, which in turn result in several pathfinding behaviors, such as outgrowth, retraction, stalling, and turning. Some molecular cues may have inhibitory or repulsive effects, as shown for collapsin-1, which cause total growth cone collapse (Muller et al. 1996) . In 1996 a new gene family, homologue of unc-33 in Caenorhabditis elegans, was identified as dihydropyrimidinase and three proteins with differentiated tissue distribution were found and named dihydropyrimidinase-related protein (Hamajima et al. 1996) . Their activity seems to be involved in the process of axonal outgrowth mediated by extracellular signals (Hamajima et al. 1996) . DRP-2, also referred to as collapsin response mediator protein 2 (CRMP-2), is a cytosolic protein that presents high homology with mouse UNC-33, rat TOAD-64 (turned on after division, 64 kDa), and chicken CRMP-62, proteins extensively studied for their role in pathfinding and migration of neurons (Goshima et al. 1995; Minturn et al. 1995) . These proteins are abundant in the nervous system, especially during development and, although TOAD-64 disappears in adult mammalian brain (Wang and Strittmatter 1996) , DRP-2 remains expressed in adult brain, suggesting that the process of axonal outgrowth is important as mechanism of repair and regeneration of adult neurons. Additionally, evidence that CRMP-2 is involved in regulating the dynamics of microtubules has been recently reported . Mutation in the unc-33 gene of C. elegans leads to severely uncoordinated movements, with premature termination of axonal endings that are abnormally swollen (Hedgecock et al. 1985; Desai et al. 1988) . In fetal Down's syndrome (DS) brain, the level of DRP-2 is decreased (Weitzdoerfer et al. 2001) , suggesting a crucial role of this protein in promoting correct synaptogenesis and neuronal differentiation and migration, processes that are reportedly abnormal in DS (Becker et al. 1991) . In adult DS brain, the level of DRP-2 is still dysregulated at the protein level and down-regulated at the mRNA level, and in AD brain the same inconsistent pattern in DRP-2 expression is reported, with a decreased mRNA expression in several regions of the brain (Lubec et al. 1999) . It is thus conceivable that loss of DRP-2, which is implicated in the developmental process of the nervous system and its repair in adult brain, is strictly related to the neuronal inability to correctly develop in fetal stage and regenerate when neuronal loss takes place, as in AD brain. Our findings of increased oxidative modifications of DRP-2 in AD brain compared with control brain establishes a potential link between oxidation-mediated loss in protein function and neuritic regeneration and plasticity. In AD brain, DRP-2 is associated with neurofibrillary tangles (Yoshida et al. 1998) , where it shares the high level of phosphorylation of tau . These findings have been associated with abnormal neuritic and axonal outgrowth of tangle-bearing neurons and thus acceleration of neuritic degeneration, due to the depletion of the soluble, cytosolic DRP-2 pool. The presence of oxidized key amino acids on the protein, which we report as a target of protein oxidation in AD brain, might favor the reported interaction and binding to paired helical filaments, the presence of which is considered to be related to the neuronal loss in AD brain. DRP-2, which provides adult human brain with the capability of repairing and maintaining the plasticity of neuronal connections, is significantly more oxidized in AD brain, increasing the potential for neuritic degeneration due to a deficiency of the repair system. It is interesting to speculate that the large number of neuropil threads in AD brain might be accounted for by this mechanism.
a-Enolase is a one of the subunits composing the enzyme enolase, which interconverts 2-phosphoglycerate and phosphoenolpyruvate in glycolysis. The active enzyme is a dimer consisting of three different subunits named a, b, and c. The homodimers aa, bb, and cc and heterodimers ac and ab have been found in human tissue. The ac and cc isoforms are the predominant dimers in the brain, representing the neuronspecific enolases, while other forms are mostly present in the heart and skeletal muscle (Keller et al. 1994) . The c-type enolase subunit is mainly located in neurons, while a-type subunits are in glial cells. Studies on the enolase activity distribution (Schmechel et al. 1987) in human brain have not shown any significant difference in the relative proportions of the distinct isoforms with respect to age, although a switch-over from the a to the c form has been demonstrated to take place in the developing brain. In AD brain, a proteomics study of protein levels in several regions of the brain demonstrated that the level of the a-subunits is increased compared with control brain (Schonberger et al. 2001) . The reduced glucose metabolism observed in AD brain (Messier and Gagnon 1996) , especially in the temporoparietal and frontal areas (Mielke et al. 1996) , suggests a possible accumulation of glycolytic enzymes in the brain in response to the metabolic alteration. The present finding that a-enolase is significantly more oxidized in AD brain compared with control brain suggests a possible relationship between glycolytic enzymatic impairment and AD glucose hypometabolism. It is well established that protein oxidation often results in loss in protein function, and consequently the rate of removal of oxidized proteins by proteinases may decrease due to the oxidative modification on the amino acids (Butterfield and Stadtman 1997) . The accumulation of a-enolase, which was increased in AD brain, might be a result of amino-acid oxidation demonstrated by the present study.
The cerebral decrease of energy metabolism due to the reduced metabolic rate of glucose, together with dysregulation of Ca 2+ -homeostasis, ammonia toxicity and accumulation of glycogen represent stress conditions capable of inducing heat shock proteins (HSP). These molecular chaperones mediate folding and assembly of other proteins. Their protective effect has been shown in cells (Mosser et al. 1997) , and in particular, HSP-70 protected against apoptosis by inhibiting caspase cascade activation (Mosser et al. 2000) . It is thus conceivable that the loss of the HSP family of proteins may play a role in neuronal death associated with AD. The HSP-70 family presents high homology and shares several functions in protein assembly, but the level of each single chaperone protein in response to stress condition may vary. HSP-70.1 is highly stress-induced (Lovis et al. 1994; Akcetin et al. 1999) , while heat shock cognate (HSC)-71 is the constitutive isoform, recruited by the cell as a primary defense against unfavorable conditions. In AD, the expression of HSPs has been proposed as a defensive mechanism of response to amyloid fibrils formation, because these molecular chaperones are capable of preventing aggregation of other proteins and in particular inhibiting self-assembly of polyglutamine proteins into amyloid-like fibrils (Dworniczak and Mirault 1987) . HSC-71 (also known as HSC-73) is involved in the degradation of proteins with abnormal conformation by binding to a particular peptide region and labeling it for proteolysis (Kouchi et al. 1999) . Kouchi et al. (1999) recently reported that, in the presence of proteasome inhibitors, HSC-71 interacts with the cytoplasmic domain of the amyloid precursor protein (APP), the appropiate cleavage of which results in deposition of amyloid-b peptide in AD brain. This finding suggests that HSC-71 might be involved in the structural maintenance of the proteasome and conformational recognition of mis-folded proteins by proteases, raising the possibility that HSC-71 has a functional role in the cell. Yoo et al. (2001) recently reported a decreased expression of HSC-71 in several regions of the AD brain, although only temporal cortex presented a statistically significant decrease. In the present study, an increased level of oxidation of HSC-71 in AD brain is found, although not significantly different from control brain. These data are in accordance with the findings of Yoo et al. (2001) , who showed a decreased, but statistically insignificant, expression level of HSC-71 in inferior parietal region in AD. The increased oxidation level of HSC-71, which may relate to the aberrant expression reported in AD brain, is probably more accentuated in brain regions more severely affected by the disease. However, these observations in IPL suggest a possible role of HSC in delaying AD progression and its putative decreased activity, due to oxidation, may be consistent with some of the neuropathological and biochemical abnormalities in AD brain.
Not all the proteins that appear on the 2D-map are recognized by anti-DNP antibody, but among the oxidized proteins detected on the Oxyblot, only a relative few exhibit increased protein carbonyl content in AD. HSC-71 and the previously identified tubulin (Aksenov et al. 2001) are examples in which oxidation in AD brain does not significantly differ from control brain. The concept that specific proteins are more prone to free radical oxidation raises the possibility of new roles of protein oxidation in AD neurodegeneration. It is well established that oxidation is one of the most important causes of brain protein damage and dysfunction (Berlett and Stadtmann 1997; Butterfield and Stadtman 1997) . It is thus plausible that decreased activity of oxidized enzymes might impair the metabolic pathway in which they are involved, from which cell abnormalities result. In addition, the notion that radicals are important mediators of cell growth control, cell differentiation and inflammation (Kamata and Hirata 1999) raises the question whether protein oxidation also plays a role in modulating intracellular signaling events. The mechanism of transcription is strictly dependent on the intracellular redox balance (Kamata et al. 1999; Schoonbroodt and Piette 2000) , which might be affected by protein oxidation. Recently, research in atherosclerosis has shown that oxidized lowdensity lipoproteins (ox-LDL) play a role in the proinflammatory process by activating intracellular signaling pathways (Leonarduzzi et al. 2000) . Additionally, advanced oxidation protein products (AOPP) have been proposed as activators of dendritic cell-mediated antigen response (Alderman et al. 2002) . It seems reasonable to suggest a role for free radicalmediated reaction, not only as toxicological events, but also as modulators of cell function, by acting as ÔsensorsÕ of critical cellular stress.
The results presented in this report, showing oxidation of three key enzymes in cellular metabolism, DRP-2, a-enolase and HSC-71, demonstrate that the process of free radicalmediated protein modification is a crucial event in AD and suggest protein oxidation as part of the mechanism of neurodegeneration in AD brain.
